FOREIGN NEWS

Israel’s IIBR Completes Development Phase Of Covid-19 Antibody

Israel's IIBR Completes Development Phase Of Covid-19 Antibody

“I am proud of the Biological Institute staff, who have made a major breakthrough,” Defense Minister Naftali Bennett said.

 

The Israel Institute for Biological Research (IIBR) has completed the development phase of COVID-19 antibody or passive vaccine, according to a statement by the Defense Ministry.
Defense Minister Naftali Bennett visited the Ness Ziona-based lab on Monday and was briefed by the research team, who revealed a breakthrough antibody that attacks the virus and neutralizes it in the body.

Leave a Comment